GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Gross Margin %

Novomics Co (XKRX:283100) Gross Margin % : 22.50% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Novomics Co's Gross Profit for the six months ended in Dec. 2023 was ₩42.8 Mil. Novomics Co's Revenue for the six months ended in Dec. 2023 was ₩190.1 Mil. Therefore, Novomics Co's Gross Margin % for the quarter that ended in Dec. 2023 was 22.50%.


The historical rank and industry rank for Novomics Co's Gross Margin % or its related term are showing as below:

XKRX:283100' s Gross Margin % Range Over the Past 10 Years
Min: -90.73   Med: 22.5   Max: 45.03
Current: 22.5


During the past 7 years, the highest Gross Margin % of Novomics Co was 45.03%. The lowest was -90.73%. And the median was 22.50%.

XKRX:283100's Gross Margin % is ranked worse than
82.78% of 749 companies
in the Biotechnology industry
Industry Median: 60.9 vs XKRX:283100: 22.50

Novomics Co had a gross margin of 22.50% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Novomics Co was 0.00% per year.


Novomics Co Gross Margin % Historical Data

The historical data trend for Novomics Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Gross Margin % Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial -90.73 -9.87 45.03 34.13 22.50

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin % Get a 7-Day Free Trial -90.73 -9.87 45.03 34.13 22.50

Competitive Comparison of Novomics Co's Gross Margin %

For the Biotechnology subindustry, Novomics Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novomics Co's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novomics Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Novomics Co's Gross Margin % falls into.



Novomics Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Novomics Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=42.8 / 190.103
=(Revenue - Cost of Goods Sold) / Revenue
=(190.103 - 147.322) / 190.103
=22.50 %

Novomics Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=42.8 / 190.103
=(Revenue - Cost of Goods Sold) / Revenue
=(190.103 - 147.322) / 190.103
=22.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Novomics Co  (XKRX:283100) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Novomics Co had a gross margin of 22.50% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Novomics Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Novomics Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co (XKRX:283100) Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co (XKRX:283100) Headlines

No Headlines